Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

766
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
766
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

683
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
683
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

485
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
485
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

413
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
413
Kidney Structure01:45

Kidney Structure

75.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.5K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

498
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
498

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis" [European Journal of Internal Medicine 147 (2026) 106742].

European journal of internal medicine·2026
Same author

Drug interaction between maribavir and rifampin: a case report.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026
Same author

Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis.

Kidney international reports·2026
Same author

Thrombotic Microangiopathy, Cryoglobulinemia, and Acute Kidney Injury in Patients With Monoclonal Gammopathy: A Case Series.

American journal of hematology·2026
Same author

Copeptin is a reliable biomarker of vasopressin and is associated with urine osmolality in patients on peritoneal dialysis.

Journal of nephrology·2026

Related Experiment Video

Updated: Feb 12, 2026

A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys
10:51

A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys

Published on: December 2, 2014

11.5K

Porphyria and kidney diseases.

Nicolas Pallet1,2,3,4, Alexandre Karras1,2,3, Eric Thervet1,2,3

  • 1INSERM U1147, Centre Universitaire des Saints Pères, Paris, France.

Clinical Kidney Journal
|April 13, 2018
PubMed
Summary

Kidney health is closely linked to haem metabolism, with disruptions causing kidney disease. Understanding these complex interactions is vital for managing conditions like porphyria and end-stage renal disease.

Keywords:
acute intermittent porphyriaacute kidney injurychronic kidney diseaseporphyriaporphyria cutanea tarda

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K
Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

18.6K

Related Experiment Videos

Last Updated: Feb 12, 2026

A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys
10:51

A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys

Published on: December 2, 2014

11.5K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K
Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

18.6K

Area of Science:

  • Biochemistry
  • Nephrology
  • Genetics

Background:

  • Kidneys synthesize significant amounts of haem, essential for renal physiology.
  • Disruptions in haem metabolism are interconnected with kidney diseases, including acute intermittent porphyria and end-stage renal disease.
  • Conditions like porphyrin accumulation and iron overload in end-stage renal disease can inhibit enzymes, leading to porphyria cutanea tarda.

Purpose of the Study:

  • To review the intricate relationship between kidney physiology and pathology in porphyria.
  • To highlight the clinical significance of porphyria-associated kidney disease.
  • To inform physicians about these complex interactions and evolving therapeutic strategies.

Main Methods:

  • Literature review of scientific articles and clinical studies.
  • Analysis of pathophysiological mechanisms linking porphyria and kidney disease.
  • Synthesis of current knowledge on therapeutic interventions.

Main Results:

  • Haem metabolism is critical for kidney function; its dysregulation impacts renal health.
  • End-stage renal disease presents conditions predisposing to specific porphyrias.
  • Evolving therapeutic strategies and understanding of pathophysiology are changing clinical management.

Conclusions:

  • The interplay between porphyria and kidney disease is complex and clinically significant.
  • Physicians must be aware of these interactions for effective patient care.
  • Further research and understanding of these mechanisms are crucial for improved outcomes.